Keywords: UCB, Neupro, US re-launch, Parkinson's disease, Restless legs syndrome, RLS

UCB's Neupro re-launched in USA for Parkinson's and RSL

Article | 16 July 2012

Belgium drugmaker UCB (Euronext Brussels: UCB) said yesterday that its Neupro (rotigotine transdermal system) is now available in US pharmacies. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in